BRIEF-Insys Therapeutics reports preliminary estimated revenues from Subsys for Q3 2016 to be $54 mln -$55 mln
October 13, 2016 at 06:57 AM EDT
* Insys Therapeutics reports preliminary estimated revenues from subsys for the third quarter 2016
